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INTRODUCTION
 Neurosarcoidosis affects approximately 5% of patients with 
sarcoidosis.1 The majority of patients present with neurologic 
symptoms due to involvement of the meninges, hypothala-
mus, pituitary gland, or cranial nerves.2 Spinal cord involve-
ment, or spinal sarcoid, is relatively rare and when present, is 
usually restricted to one or two spinal cord segments. Inflam-
matory extension of the spinal cord beyond three vertebral 
lengths is termed longitudinally extensive transverse myelitis 
(LETM). LETM is a rare feature of various autoimmune, infec-
tious, metabolic, and vascular derangements. Most often, it is 
associated with neuromyelitis optica. Other specific condi-
tions that have been known to cause LETM include sarcoid-
osis, systemic lupus erythematosus, B12 deficiency, syphilis, 
and spinal cord infarction.3 We present a patient with neuro-
sarcoidosis causing minimal neurologic symptoms and LETM.
CASE REPORT
 A 34-year-old African American male, with no past medi-
cal history, presented for progressing neck pain with numb-
ness and weakness in the upper extremities. Symptoms were 
first noticed after smoking K2, a synthetic cannabis. On ex-
amination, the patient demonstrated an even distribution 
of weakness noted to be 4/5 in the upper and lower extremi-
ties bilaterally with normal tone. He also had bilateral numb-
ness and tingling in the upper extremities with numbness of 
the upper back upon light touch down to the cervical and tho-
racic spine. No sensory loss below the thoracic spine or in the 
lower extremities was noted. Deep tendon reflex testing dem-
onstrated hyperreflexia in the upper and lower extremities. 
Cranial nerves 2 to 12 were intact. Babinski sign was negative. 
 Magnetic resonance imaging (MRI) of the brain showed no fo-
cal defects. MRI of the cervical spine revealed a T2 and T2 short-
tau inversion recovery (STIR), hyperintense, expansile lesion ex-
tending from the medulla to approximately T3 to T4 (Figure 1). 
In addition, contrast-enhanced MRI images showed an expans-
ile, enhancing intramedullary lesion extending from C3 to C6, 
with the most extensive portion measuring 9 mm in diameter 
(Figure 2). The patent’s angiotensin converting enzyme level was 
slightly elevated at 70 units/L (normal 12 - 68 units/L). Cerebro-
spinal fluid (CSF) analysis failed to show signs of infection, with 
a white blood cell count of 4 per cmm, elevated protein of 51 mg/
dL (normal 15 - 45) and elevated glucose level of 75 mg/dL (nor-
mal 40 - 70). Cytology was negative. No oligoclonal bands were 
observed in the CSF and the neuromyelitis optica antibody was 
negative. ESR, ANA, Anti-DNA, HIV, cryptococcus antigens, and 
syphilis titers were also negative. B12 levels were not assessed 
at this time as it was determined that the clinical picture did not 
fit that of subacute combined degeneration of the spinal cord.
 A CT of the chest demonstrated a conspicuous right hilar 
lymph node, but no perilymphatic nodules suggestive of sar-
coidosis. Additionally, the patient did not present with any 
pulmonary symptoms. The patient ultimately was treated 
with 4 mg IV dexamethasone for eight days followed by a 
12-day oral steroid taper (starting with 40 mg) and gradu-
ally regained strength in his hands and lower extremities.
Figure 1. Sagittal and axial T2 STIR images demonstrates hyper-
intense signal in the spinal cord from the medulla to C7 (arrows).
Figure 2. T1 post contrast sagittal demonstrates an enhanc-
ing expansile lesion in the spinal cord from C3 to C6 (arrow). 
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 Nine months after the initial presentation, the patient present-
ed with upper respiratory symptoms, back pain, and upper ex-
tremity numbness. On physical examination, there was mild re-
duction in proprioception and vibration in all distal extremities. 
The patient exhibited normal tone and strength in upper and 
lower extremities with no reduction in fine motor function. Deep 
tendon reflexes were +2 in the upper extremities with a slight de-
crease in triceps reflex relative to the others and a positive Babinski 
response on the left and right. Cranial nerves 2 to 12 were intact. 
 Repeat MRI showed improvement of the abnormal spinal 
cord signal, but persistent patchy post contrast enhancement in 
the cervical cord. A chest X-ray was remarkable for an ill-de-
fined right upper lung zone nodular opacity seen on the pos-
teroanterior view. A subsequent CT of the chest again showed 
right hilar lymphadenopathy with the largest right hilar lymph 
node measuring 2.5 cm x 1.8 cm (previously measured at 2.0 cm 
x 1.5 cm during the patient’s first presentation) and right lung 
consolidations and tree-in-bud opacities suggestive of an acute 
infection (Figure 3 A and B). Given the increase in lymphade-
nopathy, the patient subsequently was evaluated for pulmonary 
sarcoidosis with a transbronchial biopsy, which revealed a non-
caseating granuloma, suggesting a diagnosis of the inflamma-
tory disease. The patient originally was treated with antibiot-
ics for his upper respiratory symptoms and discharged given 
his vast improvement. However, following the biopsy results, 
the patient was prescribed a course of prednisone (40 mg for 
4 - 6 weeks) with close follow-up. Since that time the patient 
has presented to the hospital several times with well-controlled 
lung symptoms, but no neurological symptoms (Figure 3C).
Figure 3. A) Coronal CT chest with contrast in 2013 demonstrated conspicu-
ous right paratracheal and hilar lymph nodes. B) A 2014 scan demonstrated in-
creased size of the right paratracheal and hilar lymph nodes (yellow arrows). C) 
Coronal CT chest without contrast in 2015 demonstrated slight increased size 
of the right hilar lymph nodes. D) Axial CT chest without in 2015 demonstrated 
calcified lymph nodes and right hilar lymphadenopathy. (White arrows point to 
calcified granulomas, indicative of a remote infection.) Endobronchial bronchos-
copy fine needle aspiration in 2014 demonstrated noncaseating granulomas. 
DISCUSSION
 While most cases of sarcoidosis present with pulmonary 
symptoms, neurological manifestations of the disease are the 
presenting signs in more than half of the cases of neurosar-
coidosis.4 Our case was similar to previously reported stud-
ies of neurosarcoidosis where the patient presented with neu-
rological symptoms prior to a diagnosis of sarcoidosis or the 
manifestation of pulmonary symptoms. It was only after a 
remission of the patient’s initial neurologic symptoms with 
reappearance nine months later that pulmonary symptoms 
were first reported. With transbronchial biopsy proven sar-
coid, along with the imaging studies, a diagnosis of neuro-
sarcoidosis was made. Spinal cord sarcoidosis may present 
without systemic signs and isolated neurosarcoidosis eventu-
ally may present with classic pulmonary involvement as shown 
here making the initial diagnosis and treatment difficult.5 
 Neurological symptoms secondary to sarcoidosis are thought 
to be caused by disruption of the blood-brain barrier by disease 
related inflammatory factors, which subsequently allow for 
granulomatous infiltrate into neural tissues.6 While neurosar-
coidosis can present as hypothalamic dysfunction, meningitis, 
and encephalopathy, the most common manifestation in cur-
rent literature suggests cranial nerve involvement with a pre-
dilection for the facial nerve. This patient presented with upper 
and lower extremity paresis, as well as sensory defects reflect-
ing diffuse spinal cord involvement with a normal brain MRI. 
These findings, along with a previously reported case study 
in which neurosarcoidosis presented with symptoms simi-
lar to demyelinating disorders7, may suggest an even broader 
paradigm of clinical presentations than previously thought.
 Characteristic imaging findings in cases of neurosarcoidosis 
are highly variable.  Previously reported findings include dural 
and leptomeningeal enhancement with spread to the Virchow-
Robin spaces, T2 hyperintense signaling, and cranial nerve 
involvement.8 Although most MRI findings are non-specific, 
Gullapalli and Phillips9 reported a sensitivity of brain MRI of 82 
- 97% compared to sensitivities of 82% for chest radiography, 50 
- 80% for CSF abnormalities (the most common being mononu-
clear pleocytosis along with hypoglycorrhachia, elevated open-
ing pressure, and elevated total protein levels) and 50% for CSF 
angiotensin-converting enzyme levels, making MRI one of the 
best non-invasive tools for neurosarcoid diagnosis once other 
causes of the lesion have been ruled out. In one study, spinal 
lesions were reported in just 8% of patients with neurosarcoid-
osis, 50% of which also had intracranial manifestations of the 
disease.10 In most cases of spinal sarcoid, cervical cord findings 
extend one to two segments with very few reported cases of 
LETM.11 Interestingly, our case revealed diffuse cord involve-
ment with both severe edema resulting in spinal canal narrow-
ing and an increase in STIR and T2 signal from the brain stem 
to the thoracic spine at T3 to T4 without intracranial lesions.
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CONCLUSION
 In summary, we presented an atypical case of neurosarcoid-
osis with extensive spinal cord involvement, followed by pulmo-
nary manifestations nine months later, with favorable outcome 
to steroid therapy. Data on the radiographic and MRI findings 
of neurosarcoidosis as well the clinical manifestations of the 
disease vary greatly. As imaging improves and additional case 
reports are reviewed, more apt recognition of this disease pro-
cess may be achieved. This is clinically significant because while 
most symptoms undergo a relapsing and remitting course, cur-
rent literature suggests early treatment with corticosteroids or 
other immunosuppressive drugs provides the most favorable 
outcomes.12
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